Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-022025

Chief Operating Officer gave up 2,019 shares (to pay taxes)

  • Chief Operating Officer acquired 8,952 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-30 Exercise or conversion : show line 1 in the form +8,952 195,084 D
2024-06-30 Shares withheld for taxes : show line 2 in the form −2,019 $0.73 $1,476 193,065 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,952 73,271 D
Loading xslF345X05/rdgdoc.xml…